Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

NCT02803138 · clinicaltrials.gov ↗

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Ombitasvir/paritaprevir/ritonavir
DRUG: Dasabuvir
DRUG: Ribavirin
BEHAVIORAL: Patient support program

Sponsor

AbbVie